Skip to main content
Clinical Trials/NCT01250509
NCT01250509CompletedPhase 2

Effects of Stress Reduction on Eating, Fat Distribution, and Cell Aging Among Overweight Women

University of California, San Francisco1 site in 1 country53 target enrollmentStarted: November 1, 2006Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
53
Locations
1
Primary Endpoint
Change in Abdominal Fat

Study Overview

Brief Summary

The purpose of this study is to determine whether a mindfulness-based stress reduction and mindful eating program will lead to reductions in abdominal fat and total weight and improve cell aging in overweight and obese women compared to a waitlist control group.

Detailed Description

Obesity is the largest growing epidemic, with about 65% of Americans overweight (Flegal, Carroll et al. 2002). Obesity, in particular, abdominal obesity, confers increased risk for a host of diseases, including hypertension, Type 2 diabetes, and coronary heart disease, resulting in shortened life span (Fontaine, Redden et al. 2003). Psychological stress is widely cited anecdotally as a factor that causes people to engage in overeating, and studies provide strong evidence that stress can promote obesity. Stress induces selective preference of sweet, high-fat food and increases visceral fat depots. The telomere maintenance system (telomerase activity and telomere length)are markers of cellular aging and predict mortality (Cawthon et al, 2003)and have been linked to both psychological stress and components of the metabolic syndrome. The proposed study adapts a program called Mindfulness-Based Stress Reduction (MBSR) that has been shown to be effective in a variety of other stress-related conditions. Fifty overweight, pre-menopausal women at risk for the Metabolic Syndrome will be randomized in a 1:1 distribution to either a 3-month intervention to reduce stress and overeating [Craving and Lifestyle Management with Mindfulness (CALMM)] or wait list control group. The primary outcome measures include amounts of abdominal fat, weight, and telomerase activity. Data from this study are intended to provide pilot data for use in planning a larger randomized, controlled trial that will investigate the effects of the CALMM intervention on the metabolic and psychological processes assessed in this pilot study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Pre-menopausal
  • •BMI (25 - 40)
  • •Weight < 300 lbs.
  • •Negative urine glucose test

Exclusion Criteria

  • •Inability to provide informed consent
  • •Age < 21 or menopausal as determined by self-report
  • •DSM-IV diagnosis of an eating disorder
  • •Any substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention
  • •Factors that confound relations between stress and eating, including, drug abuse and use of medications containing corticosteroids.
  • •Polycystic Ovary Syndrome
  • •Breastfeeding (due to interference with stress hormone measurement)
  • •Non English speaker
  • •Pregnant as determined by pregnancy test at screening visit or planning to get pregnant in the next 6 months
  • •Previous MBSR training and/or current meditation, yoga, or other mind-body practice
  • •Initiation of new class of psychiatric medications in past 2 months.
  • •Currently on a weight loss diet

Arms & Interventions

CALMM

Experimental

Participants receiving the 'Craving and Lifestyle Management through Mindfulness' intervention, i.e. program that combines stress reduction with mindful eating practices.

Intervention: Craving and Lifestyle Management through Mindfulness (Behavioral)

Waitlist Control

No Intervention

Participants were waitlisted for the intervention during the experimental phase.

Outcomes

Primary Outcomes

Change in Abdominal Fat

Time Frame: Change from Baseline in Abdominal Fat (baseline and 4 months)

Whole-body dual energy X-ray absorptiometry (DEXA) scans were performed to assess body fat distribution. The DEXA densitometry (GE Healthcare Lunar Prodigy, Madison, Wis, USA) was adjusted to the fan beam mode and EnCore software version 9.15 was used. The primary region of interest was fat tissue from a rectangular region in the abdominal area defined by the upper boundary of the second lumbar vertebra to the lower edge of the fourth lumbar vertebra. The vertical sides were defined as the continuation of the lateral sides of the rib cage.

Secondary Outcomes

  • Weight(Change in Weight (baseline and 4 months))
  • Telomerase Activity(Change from Baseline in Telomerase Activity at 4 months)
  • Change in Psychological Stress (Baseline and 4 Months)(Change from Baseline in Psychological Stress)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials